Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
35.18
+0.21 (0.60%)
Sep 4, 2026, 3:00 PM CST

SHA:688363 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,6914,1955,3616,0756,3594,947
Other Revenue
3.763.769.490.60.410.55
3,6954,1995,3716,0766,3594,948
Revenue Growth
-23.36%-21.82%-11.61%-4.45%28.53%87.93%
Cost of Revenue
1,2591,3521,4821,6591,4821,118
Gross Profit
2,4352,8473,8894,4174,8773,829
Selling, General & Admin
1,7982,0553,1183,3313,4392,736
Research & Development
452.97472.14466.25446.35388.19284.34
Other Operating Expenses
64.8642.7746.4862.0173.2556.95
Operating Expenses
2,3572,6123,6563,8473,9153,083
Operating Income
77.72235.23232.36570.18961.48746.46
Interest Expense
-6.42-6.42-9.17-10.74-14.52-11.08
Interest & Investment Income
30.897.6314.1139.7850.4445.07
Currency Exchange Gain (Loss)
5.235.232.973.925.19-12.05
Other Non Operating Income (Expenses)
-10.442.58-4.761.71-3.88-2.62
EBT Excluding Unusual Items
96.99244.26235.51604.841,019765.77
Impairment of Goodwill
-3.06-3.06-74.09---
Gain (Loss) on Sale of Investments
21.2514.15-11.48-18.74-0.147.39
Gain (Loss) on Sale of Assets
1.460.42-0.11-3.42-0.240.04
Asset Writedown
28.53-2.36-0.86-1.87-0.53-3.91
Other Unusual Items
80.480.464.43120.91118.32120.9
Pretax Income
225.56333.8213.39701.721,136890.2
Income Tax Expense
2.0542.6544.99118.98174.73114.64
Earnings From Continuing Operations
223.51291.15168.41582.74961.38775.56
Minority Interest in Earnings
0.490.915.869.819.546.78
Net Income
224292.06174.27592.56970.92782.33
Net Income to Common
224292.06174.27592.56970.92782.33
Net Income Growth
319.83%67.59%-70.59%-38.97%24.10%21.14%
Shares Outstanding (Basic)
477479484482481480
Shares Outstanding (Diluted)
477479484482483483
Shares Change
-1.24%-1.09%0.48%-0.27%0.03%0.95%
EPS (Basic)
0.470.610.361.232.021.63
EPS (Diluted)
0.470.610.361.232.011.62
EPS Growth
325.10%69.44%-70.73%-38.81%24.07%20.00%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
585.28301.77-156.88-330.68-61.22491.85
Free Cash Flow Per Share
1.230.63-0.32-0.69-0.131.02
Dividend Per Share
0.1900.1900.1100.3800.6100.490
Dividend Growth
72.73%72.73%-71.05%-37.70%24.49%19.51%
Gross Margin
65.91%67.80%72.41%72.69%76.69%77.40%
Operating Margin
2.10%5.60%4.33%9.38%15.12%15.09%
Profit Margin
6.06%6.96%3.25%9.75%15.27%15.81%
Free Cash Flow Margin
15.84%7.19%-2.92%-5.44%-0.96%9.94%
EBITDA
404.28537.69471.59775.491,124866.92
EBITDA Margin
10.94%12.80%8.78%12.76%17.68%17.52%
D&A For EBITDA
326.56302.46239.23205.31162.69120.46
EBIT
77.72235.23232.36570.18961.48746.46
EBIT Margin
2.10%5.60%4.33%9.38%15.12%15.09%
Effective Tax Rate
0.91%12.78%21.08%16.96%15.38%12.88%
Revenue as Reported
4,1994,1995,3716,0766,3594,948
Advertising Expenses
-649.371,3771,7902,0511,583